Nektar Therapeutics (NKTR) Presents At 39th Annual J.P. Morgan Healthcare Conference

NEKTAR® SMARTER MEDICINE™ 39th Annual J.P. Morgan Healthcare Conference Howard Robin President & CEO January 11, 2021 2 This presentation includes forward-looking statements regarding Nektar's proprietary drug candidates, the timing of the start of and plans for ongoing or planned clinical trials with partners, the therapeutic potential of our drug candidates, the timing and outcome of regulatory decisions, and future availability of clinical trial data. Actual results could differ materially, and these sta ...